Objective To investigate the effect of exercise therapy on the psychological resilience, anxiety level, and quality of life of patients with nasopharyngeal carcinoma undergoing chemoradiotherapy. Methods A total of 154 patients with nasopharyngeal carcinoma admitted to the People's Hospital of Guangxi Zhuang Autonomous Region from October 2023 to May 2025 were enrolled as study subjects, and divided into a control group and an observation group using a random number table method, with 77 cases in each group. The control group received routine nursing care during chemoradiotherapy, while the observation group received individualized exercise intervention under a multidisciplinary collaboration model on the basis of routine nursing care, for 6 chemotherapy cycles. The intervention effects were evaluated using the Connor-Davidson Resilience Scale (CD-RISC), the Chinese version of the State-Trait Anxiety Inventory (including the state anxiety inventory [SAI] and the trait anxiety inventory [TAI]), and the head and neck cancer quality of life scale. Results Finally, 149 cases completed the intervention, with 75 in the control group and 74 in the observation group. Before intervention, there were no statistically significant differences in the total CD-RISC score and the scores of each dimension, the SAI and TAI scores, and the total head and neck cancer quality of life scale score and the scores of each dimension between the two groups (all P>0.05). After 6 cycles of intervention, the total CD-RISC score and the total head and neck cancer quality of life scale score in the observation group were higher than those in the control group, and the SAI and TAI scores were lower than those in the control group, with statistically significant differences (all P<0.05). Conclusion Exercise therapy can effectively improve the psychological resilience of patients with nasopharyngeal carcinoma undergoing chemoradiotherapy, alleviate anxiety, and improve quality of life, and can be used as an important supportive intervention during chemoradiotherapy.